Showing results (81-90 of 436) with videos related to
Sort By:
Pageof 44
The Lancet. Gastroenterology & Hepatology|August 19, 2023
NASH drug treatment development: challenges and lessonsHerbert Tilg, Christopher D Byrne, Giovanni TargherTrends in Endocrinology and Metabolism: TEM|July 6, 2013
Non-alcoholic steatohepatitis: a microbiota-driven diseaseAlexander R Moschen, Susanne Kaser, Herbert TilgCell Metabolism|October 8, 2022
Gut-liver axis: Pathophysiological concepts and clinical implicationsHerbert Tilg, Timon E Adolph, Michael TraunerGut|January 16, 2024
MASLD: a systemic metabolic disorder with cardiovascular and malignant complicationsGiovanni Targher, Christopher D Byrne, Herbert TilgDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2018
Food, microbiome and colorectal cancerLukas Niederreiter, Timon E Adolph, Herbert TilgGut|February 22, 2014
Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regenerationMarkus Tschurtschenthaler, Jun Wang, Cornelia Fricke, et al.JAMA|November 10, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A ReviewHerbert Tilg, Salvatore Petta, Norbert Stefan, et al.Journal of Internal Medicine|October 29, 2023
Does cardiovascular risk matter in IBD patients?Herbert Tilg, Mathurin Fumery, Charlotte R H HedinCurrent Pharmaceutical Design|April 8, 2010
Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disordersAlexander R Moschen, Romana R Gerner, Herbert TilgPageof 44